Studies from Unit of Nuclear Medicine Yield New Information about Gliomas (Assessment of Therapy Response To Regorafenib By F-18-dopa-pet/ct In Patients With Recurrent High-grade Gliomas: a Case Series)

MLA

“Studies from Unit of Nuclear Medicine Yield New Information about Gliomas (Assessment of Therapy Response To Regorafenib By F-18-Dopa-Pet/Ct In Patients With Recurrent High-Grade Gliomas: A Case Series).” Clinical Oncology Week, 19 Apr. 2021, p. 1366. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.658862610&authtype=sso&custid=ns315887.

APA

Studies from Unit of Nuclear Medicine Yield New Information about Gliomas (Assessment of Therapy Response To Regorafenib By F-18-dopa-pet/ct In Patients With Recurrent High-grade Gliomas: a Case Series). (2021, April 19). Clinical Oncology Week, 1366.

Chicago

Clinical Oncology Week. 2021. “Studies from Unit of Nuclear Medicine Yield New Information about Gliomas (Assessment of Therapy Response To Regorafenib By F-18-Dopa-Pet/Ct In Patients With Recurrent High-Grade Gliomas: A Case Series),” April 19. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.658862610&authtype=sso&custid=ns315887.